Generalized Anxiety Disorder
321
39
57
199
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
70 trials with published results (22%)
Research Maturity
199 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.2%
23 terminated out of 321 trials
89.6%
+3.1% vs benchmark
23%
73 trials in Phase 3/4
35%
70 of 199 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 199 completed trials
Clinical Trials (321)
Testing Delivery Modalities of Team-Based CBT for Pediatric Anxiety in Community Health Settings.
Mindful Self-Compassion for Anxiety Disorders and Depression
Group CBT for Intolerance of Uncertainty
Qualitative Study of Student Financial Insecurity and Psychiatry
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
MBSR Mechanisms in GAD
Use of CBD in the Treatment of Anxiety
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
LIFU for Chronic Pain and Generalized Anxiety Disorder
Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder
Student Precarity and Psychiatry
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
Triage Survey for Psychiatry Research Eligibility
Group vs. Individual Metacognitive Therapy for Generalized Anxiety Disorder